Saturday, December 14, 2019
Breaking Medical Device Industry News
Home Aethlon Medical Inc.

Aethlon Medical Inc.

    Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications

    An EFS for a medical device is similar to a phase 1 study for a drug or biologic and as such this trial will enroll a small number of patients with advanced head and neck cancer who cannot be treated with surgery or radiation.

    Aethlon Medical, Inc. and SeaStar Medical, Inc. Announce Strategic Joint Cross-Licensing Agreement

    "The potential synergy of our two companies' platforms should allow penetration into multiple unaddressed markets," said Timothy C. Rodell, M.D., Interim Chief Executive Officer of Aethlon Medical.

    Aethlon Medical Announces Collaboration With Prostate On-Site Project

    Aethlon Medical Inc. and its diagnostic subsidiary, Exosome Sciences, in collaboration with the Translational Genomics Research Institute (TGen) and the Prostate On-Site Project (POP), announced that Aethlon, TGen and POP will engage with participants for their studies of chronic traumatic encephalopathy (CTE) in living individuals during the 18th annual Jerry Colangelo Sports Legends Golf Classic in Phoenix.

    RECENT COMMENTS